Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists. - Wikidata - wikimedia - TriplyDB

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

http://www.wikidata.org/entity/Q35438088

about

Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.Radiation therapy generates platelet-activating factor agonists Emerging targets for combination therapy in melanomas.Advances in Immunotherapy for Melanoma: A Comprehensive Review.Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

P2860

Q37156655-B3E6114D-B8E7-4ACD-8365-A1D7B57AC0F4 Q37190440-434BA2D7-CEA2-4027-A1E5-0145689DD7A3 Q38602788-152F814D-97C4-4F75-BB3E-AEF4ED8CB751 Q38636521-E9250435-C057-4965-B4D7-83ECF24B37CE Q41472852-CFA59721-E6CB-426A-8F91-4055DD70A2EF Q49829026-C9956601-2FFF-439F-BBF8-63D0AE9444FC Q50062795-17FE8136-5BEA-4F7E-9A43-55580DF42CF6

P2860

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

http://www.wikidata.org/entity/Q35438088

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@ast

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@en

type

label

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@ast

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@en

prefLabel

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@ast

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

@en

P1433

Q35438088-ED8F7B12-9A25-48D5-9381-5F4AF9451F87

P1476

Q35438088-BE7712B1-D4EC-40AD-9DCC-D471F554AEF9

P2093

Q35438088-84724A72-78E7-4428-BFC9-7FC38BA851DD

Q35438088-E45C7B52-9613-4C0C-8D38-DCA70E5F1750

P2860

Q35438088-001778E0-0790-4060-91C6-B2A8EED45136

Q35438088-01F2122B-49FF-46F3-A342-3EE9B25F8EBE

Q35438088-08E57F71-7F46-4A6E-8F63-9DE9CA96851E

Q35438088-119FB5EC-2C24-4D1C-87D8-2ED3A6BEF8CC

Q35438088-16E1E479-C501-4299-9BE3-5AB00A4CB101

Q35438088-17B11941-2327-4ECB-80BE-F487778399B9

Q35438088-2FE40653-6616-4436-B229-E39F9CB5489A

Q35438088-3A114FE2-4701-4D0E-BFF0-A446BBE98E0D

Q35438088-48810ED4-53B7-4D17-943D-1BEF0CD795D0

Q35438088-49614665-C27B-4AFA-A1B8-BB1B30767055

P304

Q35438088-79F26435-B748-4D0A-B927-856E13CBD52F

P31

Q35438088-5768247C-D106-4CF7-B5BE-FB9B15B5534E

P356

Q35438088-33E76BB6-DD6D-4534-82AA-CC038D530C4D

P407

Q35438088-9DA3BE8F-4406-4F02-AE88-E346ADF3D944

P478

Q35438088-68470A73-E5AC-4B1C-8ABD-5E5B37C06CEE

P50

Q35438088-D987E4BA-97AF-452B-BA5E-9E04908F3A9D

P577

Q35438088-942E588C-8669-4100-A708-07F874DC72B7

P5875

Q35438088-23D344C6-F9A4-4E97-AFD1-52BE8406E979

P698

Q35438088-CEDFC9C1-34D4-466A-913C-205CCDF6CA6E

P921

Q35438088-2EEB5001-7D82-4A1E-955A-D42F20138993

P932

Q35438088-815CE1CA-0066-4305-A0F5-9667D8EE2A34

P356

P1433

Mediators of Inflammation

P1476

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists

@en

P2093

Matheus Ferracini

http://www.w3.org/2001/XMLSchema#string

Ravi P Sahu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis

Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists.

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide.

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.

Systemic chemotherapy in the treatment of malignant melanoma.

Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.

Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.

P304

820543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/820543

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey B Travers

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275223847

http://www.w3.org/2001/XMLSchema#string

P698

25922565

http://www.w3.org/2001/XMLSchema#string

P921

P932

4398925

http://www.w3.org/2001/XMLSchema#string